figtree know the aussie market well, page-3

bello - actually, I doubt that there is a better method available for getting funding.

I also doubt whether the PRR project stacks up commercially, if it did it would be partnered up with big pharma right now. I'm not saying it doesn't work, just that all of the costs of trials, combined with short patent life etc mean that the economics don't stack up.

What I object to is the excitement that the Figtree deal in some way "validates" the PRR science when Figtree in fact look to be no more credible than most punters on this forum, and they have no capacity (at this stage anyway) to hold onto the stock for more than about 30 days as they need to sell down each month's allocation to fund their next cheque.

Figtree may well have capacity to execute a good little pump n dump. . . . .and that is what investors/traders on this site should be considering and making sure they take advantage of rather than falling victim to.